Pulsenmore Ltd. Ordinary Shares (PLSM) is a publicly traded the market company. As of May 21, 2026, PLSM trades at $4.23 with a market cap of $31.80M and a P/E ratio of 0.00. PLSM moved +0.00% today. Year to date, PLSM is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $3.00 to $10.28. Rallies surfaces PLSM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Pulsenmore Reports 374% Revenue Surge to $12.5M, Secures FDA De Novo and CE Approval: Pulsenmore reported 2025 revenue of $12.5 million, a 374% increase driven by a $9.6 million GE settlement, and narrowed net loss to $5 million from $10 million. It had $21.7 million in liquid assets at year-end 2025 and secured FDA De Novo plus CE approval for its home-use ultrasound.
| Metric | Value |
|---|---|
| Price | $4.23 |
| Market Cap | $31.80M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.28 |
| 52-Week Low | $3.00 |
| Volume | 3.91K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
PLSM analyst coverage data. Average price target: $0.00.